Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes

被引：2
作者：
Chatterjee, Saurav [1 ,2 ]
Chatterjee, Sanjay [3 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
[2] Providence VAMC, Providence, RI USA
[3] Apollo Gleneagles Hosp, Kolkata, W Bengal, India
来源：
ANNALS OF INTERNAL MEDICINE | 2013年 / 158卷 / 08期
关键词：
METAANALYSIS;
D O I：
10.7326/0003-4819-158-8-201304160-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
[21]   Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes A system review and meta-analysis [J].
Wang, Ben ;
Sun, Yan ;
Sang, Yiquan ;
Liu, Xuekui ;
Liang, Jun .
MEDICINE, 2018, 97 (46)
[22]   Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients [J].
Soejima, Hirofumi ;
Ogawa, Hisao ;
Morimoto, Takeshi ;
Okada, Sadanori ;
Matsumoto, Chisa ;
Nakayama, Masafumi ;
Masuda, Izuru ;
Jinnouchi, Hideaki ;
Waki, Masako ;
Saito, Yoshihiko ;
JPAD Trial Investigators .
HEART AND VESSELS, 2023, 38 (11) :1371-1379
[23]   Association of Sodium-Glucose Cotransporter-2 Inhibitors vs Dipeptidyl Peptidase-4 Inhibitors With Pneumonia, COVID-19, and Other Adverse Respiratory Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis [J].
Wang, Mengna ;
Li, Ming ;
Wang, Libin ;
Wang, Fang ;
Cao, Xulin ;
Li, Shengyou ;
Zheng, Zhichang .
CANADIAN JOURNAL OF DIABETES, 2024, 48 (06) :364-372.e1
[24]   Dipeptidyl peptidase-4 inhibitors and risk of arthralgia: A systematic review and meta-analysis [J].
Men, P. ;
He, N. ;
Song, C. ;
Zhai, S. .
DIABETES & METABOLISM, 2017, 43 (06) :493-500
[25]   Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin [J].
Peng, Xiaomei ;
Jiang, Dingfeng ;
Liu, Dongju ;
Varnado, Oralee J. ;
Bae, Jay P. .
PATIENT PREFERENCE AND ADHERENCE, 2016, 10 :1539-1546
[26]   Dipeptidyl Peptidase-4 Inhibitors and the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes in Taiwan A Population-Based Cohort Study [J].
Lai, Yun-Ju ;
Hu, Hsiao-Yun ;
Chen, Hsin-Hua ;
Chou, Pesus .
MEDICINE, 2015, 94 (43)
[27]   Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus [J].
Sato, Akihiko ;
Yoshihisa, Akiomi ;
Kanno, Yuki ;
Takiguchi, Mai ;
Miura, Shunsuke ;
Shimizu, Takeshi ;
Nakamura, Yuichi ;
Yamauchi, Hiroyuki ;
Owada, Takashi ;
Sato, Takamasa ;
Suzuki, Satoshi ;
Oikawa, Masayoshi ;
Yamaki, Takayoshi ;
Sugimoto, Koichi ;
Kunii, Hiroyuki ;
Nakazato, Kazuhiko ;
Suzuki, Hitoshi ;
Saitoh, Shu-ichi ;
Takeishi, Yasuchika .
ESC HEART FAILURE, 2016, 3 (02) :77-85
[28]   Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials [J].
Chai, Shangyu ;
Zhang, Ruya ;
Zhang, Ye ;
Carr, Richard David ;
Zheng, Yiman ;
Rajpathak, Swapnil ;
Yu, Miao .
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[29]   Beneficial Effects of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure With Preserved Ejection Fraction and Diabetes [J].
Enzan, Nobuyuki ;
Matsushima, Shouji ;
Kaku, Hidetaka ;
Tohyama, Takeshi ;
Nagata, Takuya ;
Ide, Tomomi ;
Tsutsui, Hiroyuki .
JACC-ASIA, 2023, 3 (01) :93-104
[30]   Cardiovascular events and all-cause mortality in patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials [J].
Mannucci, Edoardo ;
Nreu, Besmir ;
Montereggi, Chiara ;
Ragghianti, Benedetta ;
Gallo, Marco ;
Giaccari, Andrea ;
Monami, Matteo .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (10) :2745-2755
12345